Jung‐Hwan Yoon

21.0k citations
436 papers · 14.1k · 3 hit papers · h-index 61

Impact in

  • Hepatology top 0.05%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Hepatitis C virus research
    • Liver physiology and pathology
  • Epidemiology top 0.2%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 116
    • Hepatitis C virus research 45
    • Liver Disease and Transplantation 26
    • Liver physiology and pathology 12
    • Liver Disease Diagnosis and Treatment 98
    • Hepatitis B Virus Studies 82

Jung‐Hwan Yoon

406 papers receiving 13.9k citations

Jung‐Hwan Yoon's Hit Papers

EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization. 2024 · 101 citations
1010+5+11Years since publication2505007501000

Peers

Jung‐Hwan Yoon
Comparison fields: 5 of 150
  • Hepatology 5.5k
  • Epidemiology 5.2k
  • Cancer Research 1.4k
  • Oncology 1.6k
  • Pathology and Forensic Medicine 942
Replace Michio Sata with:
Michio Sata Japan
Jean‐François Dufour Switzerland
Anthony W.H. Chan Hong Kong
Markus Peck‐Radosavljevic Austria
Swan N. Thung United States
Takeshi Okanoue Japan
Tatiana Kisseleva United States
Hitoshi Yoshiji Japan
James G. Kench Australia
Claus Hellerbrand Germany
Jung‐Hwan Yoon relative to Michio Sata Japan Michio Sata's profile →
Citations per field
00.5×4.1×
Michio Sata · 1×
Citations per year

Countries citing papers authored by Jung‐Hwan Yoon

Since Specialization
Citations

This map shows the geographic impact of Jung‐Hwan Yoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Hwan Yoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Hwan Yoon more than expected).

Fields of papers citing papers by Jung‐Hwan Yoon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Hwan Yoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Hwan Yoon. The network helps show where Jung‐Hwan Yoon may publish in the future.

Co-authors

The 25 scholars most cited alongside Jung‐Hwan Yoon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jung‐Hwan Yoon Line = papers co-authored together Jung‐Hwan Yoon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 436 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
Hit paper breakdown →
20091145
2 2015411
3 2012261
4 2013255
5 2011246
6 2016243
7 2012229
8
Liver homeostasis is maintained by midlobular zone 2 hepatocytes
Hit paper breakdown →
2021173
9 2002161
10 2015158
11 2004157
12 2010154
13 2002152
14 2003133
15 2007131
16 2015129
17 2008128
18 2002128
19 2010122
20 2004113

About Jung‐Hwan Yoon

Jung‐Hwan Yoon is a scholar working on Hepatology, Epidemiology, Molecular Biology, Cancer Research and Oncology, having authored 436 papers that have together received 14.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (116 papers), Liver Disease Diagnosis and Treatment (98 papers), Hepatitis B Virus Studies (82 papers), Hepatitis C virus research (45 papers), Liver Disease and Transplantation (26 papers), Cancer, Hypoxia, and Metabolism (20 papers), Cancer, Lipids, and Metabolism (13 papers) and Liver physiology and pathology (12 papers). The work is most often cited by research in Hepatology (5.5k citations), Epidemiology (5.2k citations), Cancer Research (1.4k citations), Oncology (1.6k citations) and Pathology and Forensic Medicine (942 citations). Jung‐Hwan Yoon has collaborated with scholars based in South Korea, Ethiopia and United States. Frequent co-authors include Yoon Jun Kim, Jeong‐Hoon Lee, Su Jong Yu, Won Kim, Gregory J. Gores, Hyo-Suk Lee, Eun Ju Cho, Donghee Kim, Goh Eun Chung and Chung Yong Kim. Their work appears in journals such as Journal of Hepatology, PLoS ONE, Gut and Liver, Hepatology and Journal of Medical Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact